Literature DB >> 11908946

Cross-reactive mycobacterial and self hsp60 epitope recognition in I-A(g7) expressing NOD, NOD-asp and Biozzi AB/H mice.

Astrid G S van Halteren1, Bart O Roep, Silvia Gregori, Anne Cooke, Willem van Eden, Georg Kraal, Marca H M Wauben.   

Abstract

The highly conserved 60 kD endogenous heat shock protein (hsp60) has been suggested to be a target for T cell recognition in autoimmune diseases such as type I diabetes. We previously reported cross-recognition of both mycobacterial hsp60 (Mt60) and self hsp60 (m60) by Mt60 immunized NOD mice. To identify the epitopes involved, we generated T cell lines against m60 or its mycobacterial counterpart and tested these lines for recognition of complete sets of overlapping peptides spanning either hsp60 sequence. T cell lines responded to identical regions in the hsp60 proteins, regardless of their degree of conservation or I-A(g7) binding-affinity. Additionally, we determined whether a protective genetic background would affect the presence of hsp60 cross-reactive T cells in the peripheral repertoire by comparing epitope recognition in I-A(g7) expressing NOD, NOD-asp and Biozzi AB/H mice. Two out of five immunodominant murine peptides were able to induce proliferation in NOD and NOD-asp Mt60 T cell lines, but not in Biozzi AB/H T cell lines. Our results point out that Mt60 immunization not necessarily leads to proliferative T cells responding to endogenous hsp60 peptides in the context of diabetes-predisposing I-A(g7). Moreover, the capacity of T cells to respond to self hsp60 is not influenced by the presence of protective I-A(g7asp). Yet, proliferation of hsp60 autoreactive T cells is solely measured in combination with insulitis and as such serves as a surrogate marker for islet inflammation. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11908946     DOI: 10.1006/jaut.2001.0578

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  5 in total

1.  Humoral immune responses of type 1 diabetes patients to Mycobacterium avium subsp. paratuberculosis lend support to the infectious trigger hypothesis.

Authors:  Leonardo A Sechi; Valentina Rosu; Adolfo Pacifico; Giovanni Fadda; Niyaz Ahmed; Stefania Zanetti
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

2.  Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes.

Authors:  V A L Huurman; P E van der Meide; G Duinkerken; S Willemen; I R Cohen; D Elias; B O Roep
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

Review 3.  Mini-chaperones: potential immuno-stimulators in vaccine design.

Authors:  Azam Bolhassani; Sima Rafati
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

4.  Specific immunoassays confirm association of Mycobacterium avium Subsp. paratuberculosis with type-1 but not type-2 diabetes mellitus.

Authors:  Valentina Rosu; Niyaz Ahmed; Daniela Paccagnini; Gerald Gerlach; Giovanni Fadda; Seyed E Hasnain; Stefania Zanetti; Leonardo A Sechi
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

5.  Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.

Authors:  Wendy W J Unger; Todd Pearson; Joana R F Abreu; Sandra Laban; Arno R van der Slik; Sacha Mulder-van der Kracht; Michel G D Kester; Dave V Serreze; Leonard D Shultz; Marieke Griffioen; Jan Wouter Drijfhout; Dale L Greiner; Bart O Roep
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.